Education
About Us
Working with TipRanks
Follow Us
Liminatus Pharma, Inc. (LIMN)
NASDAQ:LIMN
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -2.91M | $ -2.59M | $ -2.71M | $ -2.53M | $ -7.81K |
| EBITDA | $ -2.75M | $ -1.09M | $ -2.71M | $ 4.37M | - |
| Net Income | $ -2.90M | $ -1.23M | $ -2.93M | $ 4.37M | $ -7.81K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 804.54K | $ 434.00K | $ 5.05M | $ 336.23K | $ 0.00 |
| Total Assets | $ 2.83M | $ 4.50M | $ 15.49M | $ 276.44M | $ 298.96K |
| Total Debt | $ 5.12M | $ 16.05M | $ 16.50M | $ 90.00K | $ 12.50K |
| Net Debt | $ 4.32M | $ 15.62M | $ 11.45M | $ -246.23K | $ 12.50K |
| Total Liabilities | $ 18.70M | $ 15.19M | $ 14.19M | $ 21.57M | $ 275.26K |
| Stockholders' Equity | $ -15.87M | $ -10.69M | $ 1.29M | $ 254.87M | $ 23.70K |
| Cash Flow | |||||
| Free Cash Flow | $ -3.11M | $ -3.35M | $ -869.00K | $ -1.22M | - |
| Operating Cash Flow | $ -3.11M | $ -3.35M | $ -869.00K | $ -1.22M | - |
| Investing Cash Flow | $ 1.97M | $ -819.00K | $ 263.96M | $ -276.00M | $ 0.00 |
| Financing Cash Flow | $ 1.05M | $ -450.00K | $ 5.92M | $ 277.55M | $ 0.00 |
Liminatus Pharma Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.